Top compounds associated with response to ANKRD20A4


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib gCSI pan-cancer AAC 0.0011 1
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.00067 1
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0007 1
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.00039 1
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0003 1
mRNA BRD-K66532283 CTRPv2 pan-cancer AAC -0.0002 1
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC 0.00018 1
mRNA necrostatin-7 CTRPv2 pan-cancer AAC 0.00016 1
mRNA Bosutinib CTRPv2 pan-cancer AAC 0.00014 1
mRNA linifanib CTRPv2 pan-cancer AAC 4.6e-05 1
Download CSV